Generation Bio Co.: share-based compensation expense

What this measure means

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Exact concept: us-gaap:ShareBasedCompensation. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2019-01-01 to 2024-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• Generation Bio Co.: total assets
• Generation Bio Co.: total liabilities
• Generation Bio Co.: stockholders equity
• Generation Bio Co.: cash and cash equivalents
• Generation Bio Co.: net income or loss
• Generation Bio Co.: operating cash flow
• Generation Bio Co.: capital expenditure payments
• Generation Bio Co.: contract revenue excluding tax
• Generation Bio Co.: financing cash flow
• Generation Bio Co.: investing cash flow
• Generation Bio Co.: retained earnings or deficit
• Generation Bio Co.: basic weighted-average shares
• Generation Bio Co.: diluted weighted-average shares
• Generation Bio Co.: basic earnings per share
• Generation Bio Co.: diluted earnings per share
• Generation Bio Co.: net property, plant and equipment
• Generation Bio Co.: operating income or loss
• Generation Bio Co.: current assets
• Generation Bio Co.: current liabilities
• Generation Bio Co.: current accounts payable
• Generation Bio Co.: operating expenses
• Generation Bio Co.: research and development expense

Inspect the source

Entity

Generation Bio Co. / CIK 0001733294

Captured

2026-09-21T17:25:22.445Z

SEC response SHA-256

30a378411c96ae5d3a633c9bea7aa71877e7269cfed0c5f651add445e168f15d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001733294.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))